
[Federal Register: August 31, 2009 (Volume 74, Number 167)]
[Rules and Regulations]               
[Page 44750-44751]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr31au09-5]                         

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Parts 16 and 118

[Docket No. FDA-2000-N-0190] (formerly Docket No. 2000N-0504)
RIN 0910-AC14

 
Egg Safety; Final Rule for Prevention of Salmonella Enteritidis 
in Shell Eggs During Production, Storage, and Transportation; Public 
Meetings

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice of public meetings.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing two public 
meetings to discuss the final rule concerning the prevention of 
Salmonella Enteritidis (SE) in shell eggs during production, storage, 
and transportation. The purpose of the public meetings is to explain 
the requirements of the rule and how to comply with it, and to provide 
the public an opportunity to ask questions.

Dates, Times, and Locations: See ``How to Participate in the Meetings'' 
in the SUPPLEMENTARY INFORMATION section of this document for dates and 
times of the meetings, closing dates for advance registration, 
requesting special accommodations due to disability, and other 
information regarding meeting participation.

Contact Person: For general questions about the meetings or for special 
accommodations due to a disability, contact Juanita Yates, Center for 
Food Safety and Applied Nutrition (HFS-009), Food and Drug 
Administration, 5100 Paint Branch Pkwy., College Park, MD 20740, 301-
436-1731, e-mail: juanita.yates@fda.hhs.gov.

SUPPLEMENTARY INFORMATION:

I. How to Participate in the Meetings

    Table 1 of this document provides information on participation in 
the meetings.

                                                    Table 1.
----------------------------------------------------------------------------------------------------------------
                                Date                 Address           Electronic Address     Other Information
----------------------------------------------------------------------------------------------------------------
First public meeting   September 30, 2009,    Hyatt Regency          .....................  ....................
                        from 1 p.m. to 5       Chicago, 151 East
                        p.m.                   Wacker Dr., Chicago,
                                               IL 60601
----------------------------------------------------------------------------------------------------------------
Advance registration   By September 21, 2009  We encourage you to    http://www.fda.gov/    There is no
                                               use electronic         Food/NewsEvents/       registration fee
                                               registration if        WorkshopsMeetingsCon   for the public
                                               possible.\1\           ferences/default.htm   meetings. Early
                                                                                             registration is
                                                                                             recommended because
                                                                                             seating is limited.
----------------------------------------------------------------------------------------------------------------
Request special        By September 21, 2009  See Contact Person     .....................  ....................
 accommodations due
 to a disability
¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤¤

[[Page 44751]]


Second public meeting  November 5, 2009,      The Westin Peachtree   .....................  ....................
                        from 1 p.m. to 5       Plaza Hotel, 210
                        p.m.                   Peachtree St., NW.,
                                               Atlanta, GA 30303
----------------------------------------------------------------------------------------------------------------
Advance registration   By October 26, 2009    We encourage you to    http://www.fda.gov/    There is no
                                               use electronic         Food/NewsEvents/       registration fee
                                               registration if        WorkshopsMeetingsCon   for the public
                                               possible.\1\           ferences/default.htm   meetings. Early
                                                                                             registration is
                                                                                             recommended because
                                                                                             seating is limited.
----------------------------------------------------------------------------------------------------------------
Request special        By October 26, 2009    See Contact Person     .....................  ....................
 accommodations due
 to a disability
----------------------------------------------------------------------------------------------------------------
\1\ You may also register via e-mail, mail, or fax. Please include your name, title, firm name, address, and
  phone and fax numbers in your registration information and send to: Deborah Harris, EDJ Associates, Inc.,
  11300 Rockville Pike, suite 1001, Rockville, MD 20852, 240-221-4326, FAX: 301-945-4295, e-mail: fda-CFSAN--
  Registration@edjassociates.com. Onsite registration will also be available at both meeting sites.

II. Background

    In the Federal Register of July 9, 2009 (74 FR 33030), FDA 
published a final rule, ``Prevention of Salmonella Enteritidis in Shell 
Eggs During Production, Storage, and Transportation,'' that requires 
shell egg producers to implement measures to prevent SE from 
contaminating eggs on the farm and from further growth during storage 
and transportation, and requires these producers to maintain records 
concerning their compliance with the rule and to register with FDA. FDA 
took this action because SE is among the leading bacterial causes of 
foodborne illness in the United States, and shell eggs are a primary 
source of human SE infections. The final rule will reduce SE-associated 
illnesses and deaths by reducing the risk that shell eggs are 
contaminated with SE.
    This document announces two public meetings as part of the agency's 
planned outreach initiatives regarding the final rule.

III. Transcripts

    Please be advised that as soon as a transcript is available, it 
will be accessible at http://www.regulations.gov. It may be viewed at 
the Division of Dockets Management (HFA-305), Food and Drug 
Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD. A 
transcript will also be available in either hardcopy or on CD-ROM, 
after submission of a Freedom of Information request. Written requests 
are to be sent to Division of Freedom of Information (HFI-35), Office 
of Management Programs, Food and Drug Administration, 5600 Fishers 
Lane, rm. 6-30, Rockville, MD 20857.

    Dated: August 24, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9-20856 Filed 8-28-09; 8:45 am]

BILLING CODE 4160-01-S
